SHAE RASMUS: Open Payments
NPI 1417780016 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 45 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $308 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $227 |
| Ardelyx, Inc. | 8 | $174 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| ABBVIE INC. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Novo Nordisk Inc | 3 | $46 |
| Daiichi Sankyo Inc. | 2 | $44 |
| PFIZER INC. | 2 | $40 |
Products named: IBSRELA, BREZTRI, LEQVIO, AIRSUPRA, Auvelity, GEMTESA, Kerendia, Wegovy.
Industry payments across GA — which companies pay providers there.
